CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+10.99%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$10.6B
AUM Growth
+$1.15B
(+12%)
Cap. Flow
+$331M
Cap. Flow
% of AUM
3.12%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
858
New
50
Increased
272
Reduced
342
Closed
45
Top Buys
| 1 |
Amgen
AMGN
|
$99.4M |
| 2 |
Merck
MRK
|
$74.3M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$52.7M |
| 4 |
Thermo Fisher Scientific
TMO
|
$36.6M |
| 5 |
Danaher
DHR
|
$36.3M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$86.9M |
| 2 |
Apple
AAPL
|
$60.7M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$31.9M |
| 4 |
Kimberly-Clark
KMB
|
$28.1M |
| 5 |
Arista Networks
ANET
|
$21.4M |
Sector Composition
| 1 | Healthcare | 35.9% |
| 2 | Technology | 20.42% |
| 3 | Consumer Discretionary | 9.53% |
| 4 | Communication Services | 7.72% |
| 5 | Financials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Enanta Pharmaceuticals
ENTA
$189M
| $2.93M | 0.03% |
+64,034
| New | +$2.93M |
|
427
Thomson Reuters
TRI
$78.7B
| $2.91M | 0.03% |
35,256
+21,324
| +153% | +$1.76M |
|
428
Kezar Life Sciences
KZR
$29.8M
| $2.9M | 0.03% |
60,000
| – | – |
|
|
JNCE
429
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.88M | 0.03% |
+352,760
| New | +$2.88M |
|
430
Boston Scientific
BSX
$159B
| $2.87M | 0.03% |
75,200
-6,067
| -7% | -$232K |
|
431
Teladoc Health
TDOC
$1.38B
| $2.81M | 0.03% |
12,822
+3,780
| +42% | +$829K |
|
432
ResMed
RMD
$40.6B
| $2.81M | 0.03% |
16,375
-30,510
| -65% | -$5.23M |
|
433
BCE
BCE
$23.1B
| $2.81M | 0.03% |
67,874
+1,868
| +3% | +$77.2K |
|
434
Coterra Energy
CTRA
$18.3B
| $2.77M | 0.03% |
+159,798
| New | +$2.77M |
|
435
The Mosaic Company
MOS
$10.3B
| $2.75M | 0.03% |
150,682
+3,919
| +3% | +$71.6K |
|
|
B
436
Barrick Mining Corporation
B
$48.5B
| $2.72M | 0.03% |
97,243
+11,261
| +13% | +$315K |
|
437
Avery Dennison
AVY
$13.1B
| $2.7M | 0.03% |
21,131
-467
| -2% | -$59.7K |
|
438
Lincoln National
LNC
$7.98B
| $2.69M | 0.03% |
85,721
+5,043
| +6% | +$158K |
|
439
W.W. Grainger
GWW
$47.5B
| $2.64M | 0.02% |
7,411
-332
| -4% | -$118K |
|
440
Entergy
ETR
$39.2B
| $2.6M | 0.02% |
52,806
-2,422
| -4% | -$119K |
|
441
Masimo
MASI
$8B
| $2.6M | 0.02% |
11,000
+2,000
| +22% | +$472K |
|
|
WBA
442
DELISTED
Walgreens Boots Alliance
WBA
| $2.59M | 0.02% |
72,064
+7,376
| +11% | +$265K |
|
443
Charles Schwab
SCHW
$167B
| $2.56M | 0.02% |
70,778
-3,251
| -4% | -$118K |
|
444
KeyCorp
KEY
$20.8B
| $2.56M | 0.02% |
214,510
-1,459
| -0.7% | -$17.4K |
|
|
AMRN
445
Amarin Corp
AMRN
$317M
| $2.55M | 0.02% |
30,300
| – | – |
|
446
Allogene Therapeutics
ALLO
$255M
| $2.51M | 0.02% |
66,561
-1,366
| -2% | -$51.5K |
|
447
Owens Corning
OC
$13B
| $2.49M | 0.02% |
36,134
-1,805
| -5% | -$124K |
|
448
Robert Half
RHI
$3.77B
| $2.47M | 0.02% |
46,646
-24,905
| -35% | -$1.32M |
|
449
Public Storage
PSA
$52.2B
| $2.46M | 0.02% |
11,038
+411
| +4% | +$91.5K |
|
450
Mesa Laboratories
MLAB
$356M
| $2.45M | 0.02% |
8,200
| – | – |
|